HKD 3.39
(-0.88%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.19 Billion HKD | 1.05% |
2022 | 1.18 Billion HKD | 33.45% |
2021 | 888.87 Million HKD | 75.67% |
2020 | 505.99 Million HKD | -27.79% |
2019 | 700.75 Million HKD | 1.07% |
2018 | 693.32 Million HKD | 89.19% |
2017 | 366.47 Million HKD | 76.71% |
2016 | 207.39 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 435.01 Million HKD | 0.0% |
2023 Q4 | 532.36 Million HKD | 0.0% |
2023 Q2 | 666.28 Million HKD | 0.0% |
2023 FY | 1.19 Billion HKD | 1.05% |
2022 Q4 | 597.98 Million HKD | 0.0% |
2022 FY | 1.18 Billion HKD | 33.45% |
2022 Q2 | 588.2 Million HKD | 0.0% |
2021 FY | 888.87 Million HKD | 75.67% |
2021 Q2 | 380.66 Million HKD | 0.0% |
2021 Q4 | 508.21 Million HKD | 0.0% |
2020 Q2 | 183.63 Million HKD | 0.0% |
2020 Q4 | 322.35 Million HKD | 0.0% |
2020 FY | 505.99 Million HKD | -27.79% |
2019 Q4 | 288.57 Million HKD | 0.0% |
2019 Q2 | 412.18 Million HKD | 0.0% |
2019 FY | 700.75 Million HKD | 1.07% |
2018 Q4 | 175.18 Million HKD | 0.0% |
2018 FY | 693.32 Million HKD | 89.19% |
2018 Q2 | 173.33 Million HKD | 0.0% |
2018 Q1 | 173.33 Million HKD | 0.0% |
2017 Q1 | 91.61 Million HKD | 0.0% |
2017 Q2 | 91.61 Million HKD | 0.0% |
2017 Q4 | 173.33 Million HKD | 0.0% |
2017 FY | 366.47 Million HKD | 76.71% |
2016 FY | 207.39 Million HKD | 0.0% |
2016 Q4 | 91.61 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
China Healthwise Holdings Limited | 146.31 Million HKD | -719.214% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 1.52 Billion HKD | 21.397% |